Matteo Bianchi

Matteo Bianchi is a Senior Scientist in Oncology Research and Biology Lead at Molecular Partners since June 2020, focusing on immune cell engagers, bispecific antibodies, and DARPin technology. Prior roles include Expert Scientist and Scientist at the same company, specializing in T-cell engagers, bispecific antibodies, and acute myeloid leukemia. Previous experience encompasses a Scientist position at The Janssen Pharmaceutical Companies of Johnson & Johnson, Research Scientist roles at the Institute of Medical Virology, University of Zurich, and The Scripps Research Institute, and a research background in gene therapy and immunology at the University Children's Hospital Zurich. Matteo Bianchi holds a PhD in Immunology from the University of Zurich and an M.Sc. in Biology from the University of Lausanne.